The CD85J/leukocyte inhibitory receptor-1 distinguishes between conformed and β2-microglobulin-free HLA-G molecules

  • Tsufit Gonen-Gross
  • , Hagit Achdout
  • , Tal I. Arnon
  • , Roi Gazit
  • , Noam Stern
  • , Václav Hořejší
  • , Debra Goldman-Wohl
  • , Simcha Yagel
  • , Ofer Mandelboim*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

106 Scopus citations

Abstract

For a proper development of the placenta, maternal NK cells should not attack the fetal extravillous cytotrophoblast cells. This inhibition of maternal NK cells is partially mediated via the nonclassical MHC class I molecule HLA-G. Recently, we demonstrated that HLA-G forms disulfide-linked high molecular complexes on the surface of transfected cells. In the present study, we demonstrate that HLA-G must associate with β2m for its interaction with CD85J/leukocyte Ig-like receptor-1 (LIR-1). Although HLA-G free H chain complexes are expressed on the surface, they are not recognized and possibly interfere with CD85J/LIR-1 and HLA-G interaction. The formation of these complexes on the cell surface might represent a novel mechanism developed specifically by the HLA-G protein aimed to control the efficiency of the CD85J/LIR-1-mediated inhibition. We also show that endogenous HLA-G complexes are expressed on the cell surface. These findings provide novel insights into the delicate interaction between extravillous cytotrophoblast cells and NK cells in the decidua.

Original languageEnglish
Pages (from-to)4866-4874
Number of pages9
JournalJournal of Immunology
Volume175
Issue number8
DOIs
StatePublished - 15 Oct 2005

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'The CD85J/leukocyte inhibitory receptor-1 distinguishes between conformed and β2-microglobulin-free HLA-G molecules'. Together they form a unique fingerprint.

Cite this